Construction and evaluation of a prognosis lncRNA model for hepatocellular carcinoma. Issue 9 (29th April 2020)
- Record Type:
- Journal Article
- Title:
- Construction and evaluation of a prognosis lncRNA model for hepatocellular carcinoma. Issue 9 (29th April 2020)
- Main Title:
- Construction and evaluation of a prognosis lncRNA model for hepatocellular carcinoma
- Authors:
- Li, Fulei
Bai, Lu
Li, Shasha
Chen, Yanling
Xue, Xiaofei
Yu, Zujiang - Abstract:
- Abstract: Current studies indicate that long non‐coding RNA (lncRNA) is often abnormally expressed in hepatocellular carcinoma (HCC). We intend to generate a multi‐lncRNA signal to improve the prognosis of HCC. By analyzing 12 pairs of HCC and adjacent normal mucosal tissues, 3900 differentially expressed lncrnas were identified as candidate biomarkers for the prognosis of HCC. Then, the 12‐lncrna signature was constructed using the LASSO Cox regression method and verified in the TCGA training dataset. Finally, we established a novel 12‐lncrna signature that was significantly associated with overall survival (OS) in the training data set. With the use of 12‐lncrna markers, patients in the training cohort were divided into high‐risk and low‐risk groups with significant OV differences ( P < .0001). Similar results were consistent in the TCGA verification dataset ( P = .046). Multivariate Cox model was used to analyze and construct the risk scores of selected key lncRNA and AJCC stages. The results showed that, compared with AJCC stages, lncRNA‐based risk scores were another important factor affecting the OS of patients. We found that risk scores based on lncRNA have a stronger prediction ability than the AJCC stage alone on 4‐year OS. For 4‐year survival rates, prediction combined with the lncRNA risk score and AJCC stage, model effectiveness (sensitivity and specificity) has reached to 0.750. To further explore the biological processes involved in prognostic lncRNA, all HCCAbstract: Current studies indicate that long non‐coding RNA (lncRNA) is often abnormally expressed in hepatocellular carcinoma (HCC). We intend to generate a multi‐lncRNA signal to improve the prognosis of HCC. By analyzing 12 pairs of HCC and adjacent normal mucosal tissues, 3900 differentially expressed lncrnas were identified as candidate biomarkers for the prognosis of HCC. Then, the 12‐lncrna signature was constructed using the LASSO Cox regression method and verified in the TCGA training dataset. Finally, we established a novel 12‐lncrna signature that was significantly associated with overall survival (OS) in the training data set. With the use of 12‐lncrna markers, patients in the training cohort were divided into high‐risk and low‐risk groups with significant OV differences ( P < .0001). Similar results were consistent in the TCGA verification dataset ( P = .046). Multivariate Cox model was used to analyze and construct the risk scores of selected key lncRNA and AJCC stages. The results showed that, compared with AJCC stages, lncRNA‐based risk scores were another important factor affecting the OS of patients. We found that risk scores based on lncRNA have a stronger prediction ability than the AJCC stage alone on 4‐year OS. For 4‐year survival rates, prediction combined with the lncRNA risk score and AJCC stage, model effectiveness (sensitivity and specificity) has reached to 0.750. To further explore the biological processes involved in prognostic lncRNA, all HCC samples in TCGA are divided into two groups according to the median lncRNA risk score, and analyzed the gene enrichment of high expression genes and low expression genes in KEGG data using goana in limma. The results suggest that the genes associated with tumor pathways, such as PI3K‐Akt and ECM‐receptor interaction, are highly expressed in the high risk group. Abstract : Receiver operating characteristic (ROC) analysis of the sensitivity and specificity of the survival prediction by the 12‐lncRNA risk score, AJCC stage in TCGA dataset patients. P values were from the comparisons of the area under the ROC (AUC) of 12‐lncRNA risk score combined with AJCC stage vs AUC of 12‐lncRNA risk score or AJCC stage separately. … (more)
- Is Part Of:
- Journal of cellular biochemistry. Volume 122:Issue 9(2021)
- Journal:
- Journal of cellular biochemistry
- Issue:
- Volume 122:Issue 9(2021)
- Issue Display:
- Volume 122, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 122
- Issue:
- 9
- Issue Sort Value:
- 2021-0122-0009-0000
- Page Start:
- 983
- Page End:
- 992
- Publication Date:
- 2020-04-29
- Subjects:
- GSEA -- hepatocellular carcinoma -- lncRNA -- nomogram -- prognosis -- ROC
Cytochemistry -- Periodicals
572 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4644 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jcb.29608 ↗
- Languages:
- English
- ISSNs:
- 0730-2312
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.010000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24077.xml